Who is left behind in Mass Drug Administration?
https://www.sciencedaily.com/releases/2019/11/191121141417.htm
Individuals and communities affected by NTDs are often the poorest and most marginalized. NTDs amenable to prevention through MDA programmes have been described as the "litmus test" for UHC due to the high MDA coverage rates needed to be effective and their model of community engagement for access and acceptance of medicines.
In the new work, Laura Dean of Liverpool School of Tropical Medicine, UK, and colleagues analyzed MDA programmes across Cameroon, Ghana, Liberia and Nigeria. They used both qualitative programmatic analysis and gendered intersectional theory -- which provides a framework for how power and position shape people's experiences -- to interrogate the domains of coverage within the Tanahashi Framework; availability, accessibility, acceptability, contact and effectiveness of programmes.